Pharmaceutical

Alkem Laboratories Q2 FY26 Earnings Results

● Nov 14, 2025

Alkem Laboratories, engaged in the pharmaceutical and nutraceutical business with global operations, reported steady financial results for Q2FY26. Financial Highlights:...

Orchid Pharma Q2 FY26 Earnings Results

● Nov 12, 2025

Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage...

Mankind Pharma Q2 FY26 Earnings Results

● Nov 7, 2025

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and...

Zydus LifeSciences Q2 FY26 Earnings Results

● Nov 7, 2025

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From...

Lupin Q2 FY26 Earnings Results

● Nov 7, 2025

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and...

Piramal Pharma Q2 FY26 Earnings Results

● Nov 6, 2025

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments: Contract...

Solara Active Pharma Q2 FY26 Earnings Results

● Nov 6, 2025

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading...

Aurobindo Pharma Q2 FY26 Earnings Results

● Nov 6, 2025

Aurobindo Pharma Ltd, a leading pharmaceutical company focused on active pharmaceutical ingredients and generic pharmaceuticals, reported a steady Q2FY26 financial...

Sun Pharma Q2 FY26 Earnings Results

● Nov 5, 2025

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and...

Ajanta Pharma Q2 FY26 Earnings Results

● Nov 5, 2025

Ajanta Pharma, specializing in specialty pharmaceutical manufacturing and marketing, reported a solid Q2 FY26 performance. Financial Overview: Revenues increased 14.07%...